retatrutide glp-1 gip glucagon Beyond GLP-1: Retatrutide's triple-agonist mechanism (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based protocols demand nutrition support alongside prescribing Targeting GLP-1, GIP & GCG

It Supports Muscle Preservation During Caloric Deficit GLP-1 medications work primarily by reducing appetite and slowing gastric emptying, which creates a sustained caloric deficit

What about those headlines

Glutathione influences vitamin C recycling and increases its protective effect on oxidative stress (OS)

Over-the-counter anti-inflammatory medications reduce swelling around compressed nerves

Hypopigmenting agents: an updated review on biological, chemical and clinical aspects

The post suggests asking directly about prescribing experience, follow-up protocols, and comfort managing this class of medication, plus whether monitoring happens in office or through a coordinated telehealth program